BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 386780)

  • 1. Results of multiparameter studies of T-cell lymphoid neoplasms.
    Collins RD; Waldron JA; Glick AD
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):699-707. PubMed ID: 386780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
    Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
    Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunologic approach to the pathology of malignant lymphomas.
    Lukes RJ
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):657-69. PubMed ID: 386777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic value of immunologic markers in juvenile acute lymphatic leukemias and non-Hodgkin lymphomas].
    Plüss HJ; Joller PW; Hitzig WH; Jakob M
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1379-82. PubMed ID: 314664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
    Burke JS
    Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing.
    Deegan MJ
    Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultrastructural morphometric and immunohistochemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin. Useful criteria for diagnosis.
    Payne CM; Grogan TM; Lynch PJ
    Arch Dermatol; 1986 Oct; 122(10):1139-54. PubMed ID: 3490225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic surface markers as prognostic factors for lymphomas and leukemias.
    Buchanan-Davidson DJ
    Wis Med J; 1980 Dec; 79(12):33-4. PubMed ID: 7008375
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukemias and lymphomas of thymic differentiation.
    Borowitz MJ; Falletta JM
    Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and malignant T cells in the regulation of inflammation and immunity.
    Broder S
    Agents Actions Suppl; 1980; 7():134-42. PubMed ID: 6454333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.